Through its newly launched $5-per-month prescription drug delivery program, Ro will now supply generic versions of Pfizer’s cholesterol drug Lipitor and hypertension drug Norvasc. The two drugs being added to Ro’s portfolio of nearly 500 generic drugs are authorized generics, meaning they are produced by the same manufacturer who makes the brand-name version.
“By partnering with leading manufacturers we’re able to bring more transparency and trust into the supply chain,” Ro CEO Zachariah Reitano told STAT. “We can show patients that the active ingredients were created in Ireland, for instance, and stamped in a Pfizer-run facility in France and shipped to us.”
Ro had previously partnered with Pfizer’s generics arm to supply patients with a generic version of the drugmaker’s erectile dysfunction drug.
More articles on pharmacy:
6 recent drug, device recalls
10 recent exec moves affecting the pharma industry
7 former FDA commissioners write opinion column lamenting White House’s treatment of agency
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
